BHLHE41 and breast carcinoma: The binding of SHARP1 to βTrCP1 was confirmed by immunoprecipitation followed by immunoblotting in both HEK293T cells and MDA-MB231 breast cancer cells (Fig. 1D–F and Supplementary File 1).